The peptide was discovered in 2015, and human clinical data remain scarce
B 12r appears orange-brown in solution, while B 12s appears bluish-green under natural daylight, and purple under artificial light
Safety and administration Users have reported improved sleep, skin health, and rapid muscle recovery
Common, mild side effects: Pain, redness, or itching at the injection site Mild nausea or diarrhea Headache Temporary dizziness Rare but more serious reactions: Allergic reactions (rash, swelling, breathing difficulty) Heart palpitations Low potassium levels during rapid correction of severe deficiency Very rare cases of anaphylaxis requiring emergency care Seek medical attention immediately if you experience symptoms of a serious allergic reaction
Until safety data exists, avoiding use during these periods is the only prudent approach
GLP-1 Receptor Agonists Glucagon-like peptide-1 receptor agonists were developed to treat type 2 diabetes and turned out to produce substantial weight loss